Navigation Links
American Oriental Bioengineering Announces September Investor Conferences Participation
Date:9/8/2009

NEW YORK, Sept. 8 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced the Company's participation in the following conferences:

    -- Morgan Stanley Healthcare Corporate Day, to be held September 11, 2009
       in Boston, MA.  Management will meet with institutional investors
       throughout the day.

    -- Morgan Stanley Global Healthcare Unplugged Conference, to be held
       September 14-15, 2009 in New York City. Management will meet with
       institutional investors throughout both days.

    -- Merrill Lynch/Bank of America Global Drug, Biotech & Medical Devices
       Conference, to be held September 15-17, 2009 in London. Management will
       present at 1:45pm London Time on September 16, 2009 and meet with
       institutional investors throughout all three days. A live webcast of
       the presentation will be available via the Company's website at
      http://www.bioaobo.com/ .

    -- Susquehanna Financial Group Third Annual Beijing Management Summit, to
       be held September 16-17, 2009 in Beijing, China. Management will speak
       on a panel discussion entitled, "China Pharma/Biotech Panel
       Participants," scheduled from 1:05-2:10pm Beijing Time on September 16,
       2009. In addition, management will also present at 9:45am Beijing Time
       on September 16, 2009 and meet with institutional investors throughout
       both days.

For further details, please contact your respective institutional sales representative.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device
2. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
3. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
4. American Oriental Bioengineering Announces Change in Independent Auditor
5. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
6. American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
7. American Oriental Bioengineering to Report Second Quarter 2009 Financial Results on August 7, 2009
8. American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China
9. American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
10. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
11. New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, will feature data from two clinical studies ... ASCO Gastrointestinal Cancers Symposium, held from January 19-21, in ... Napabucasin is an orally-administered investigational agent designed to inhibit ... stem cells (CSCs) possess the property of stemness – ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse ... expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables ... is planned for further growth in 2017. Extractable & Leachable evaluations have become ...
(Date:1/18/2017)... Chicago, IL (PRWEB) , ... January 18, 2017 ... ... auction on January 24th, 2017, to sell research and genetic testing lab equipment ... of service in the Northwest and Northeast regions of the United States. This ...
(Date:1/18/2017)... 18, 2017  Caris Life Sciences, a leading ... the largest private funder of pancreatic cancer research, ... the impact of immunotherapy in the treatment of ... services to identify potential trial candidates based on ... physicians and study investigators. The Lustgarten Foundation is ...
Breaking Biology Technology:
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at Trinity ... for graphene by combining the material with Silly ... sensitive pressure detector able to sense pulse, blood ... small spider.  The research team,s ... be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):